KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Castle Biosciences (CSTL) Income towards Parent Company: 2018-2025

Historic Income towards Parent Company for Castle Biosciences (CSTL) over the last 8 years, with Sep 2025 value amounting to -$501,000.

  • Castle Biosciences' Income towards Parent Company fell 122.08% to -$501,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.2 million, marking a year-over-year decrease of 300.86%. This contributed to the annual value of $18.2 million for FY2024, which is 131.75% up from last year.
  • Castle Biosciences' Income towards Parent Company amounted to -$501,000 in Q3 2025, which was down 110.99% from $4.6 million recorded in Q2 2025.
  • Castle Biosciences' Income towards Parent Company's 5-year high stood at $9.6 million during Q4 2024, with a 5-year trough of -$29.2 million in Q1 2023.
  • Over the past 3 years, Castle Biosciences' median Income towards Parent Company value was -$2.5 million (recorded in 2024), while the average stood at -$5.5 million.
  • Per our database at Business Quant, Castle Biosciences' Income towards Parent Company tumbled by 1,039.38% in 2023 and then surged by 471.71% in 2024.
  • Castle Biosciences' Income towards Parent Company (Quarterly) stood at -$6.4 million in 2021, then plummeted by 220.65% to -$20.6 million in 2022, then spiked by 87.49% to -$2.6 million in 2023, then skyrocketed by 471.71% to $9.6 million in 2024, then crashed by 122.08% to -$501,000 in 2025.
  • Its Income towards Parent Company stands at -$501,000 for Q3 2025, versus $4.6 million for Q2 2025 and -$25.8 million for Q1 2025.